Significance of encapsulated Bacteroides melaninogenicus and Bacteroides fragilis groups in mixed infections
- PMID: 6142862
- PMCID: PMC263451
- DOI: 10.1128/iai.44.1.12-15.1984
Significance of encapsulated Bacteroides melaninogenicus and Bacteroides fragilis groups in mixed infections
Abstract
Organisms of the Bacteroides melaninogenicus and Bacteroides fragilis groups are often found mixed with facultatively anaerobic organisms in infections. The relative importance of these Bacteroides groups and facultative anaerobic pathogens in mixed infections was investigated in a subcutaneous abscess model in mice. This was determined by observing the effect of antimicrobial therapy directed against one or both organisms present in the abscess. Clindamycin or metronidazole was used for treatment of infections caused by Bacteroides species, and either gentamicin, penicillin, ampicillin, or oxacillin was used for treatment of infections caused by facultative flora. In almost all instances the aerobic counterparts in the infection were more important than the unencapsulated Bacteroides species. On the other hand, encapsulated B. melaninogenicus group organisms were found to be more important in abscess formation than were group A streptococci, Streptococcus pneumoniae, Klebsiella pneumoniae, Haemophilus influenzae, and Staphylococcus aureus. Encapsulated B. fragilis group organisms were found to be more important than or as important as Escherichia coli and group D streptococci and less important than S. aureus, group A streptococci, and K. pneumoniae in induction of subcutaneous abscesses. This study demonstrates that encapsulated Bacteroides species are a factor that should be considered in the treatment of mixed infections with antibiotics.
Similar articles
-
Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.J Med Microbiol. 1988 Nov;27(3):191-8. doi: 10.1099/00222615-27-3-191. J Med Microbiol. 1988. PMID: 2903934
-
Synergism between penicillin, clindamycin, or metronidazole and gentamicin against species of the Bacteroides melaninogenicus and Bacteroides fragilis groups.Antimicrob Agents Chemother. 1984 Jan;25(1):71-7. doi: 10.1128/AAC.25.1.71. Antimicrob Agents Chemother. 1984. PMID: 6142680 Free PMC article.
-
Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis.Surg Gynecol Obstet. 1987 Dec;165(6):491-5. Surg Gynecol Obstet. 1987. PMID: 3317944
-
Pathogenicity of the Bacteroides fragilis group.Ann Clin Lab Sci. 1989 Sep-Oct;19(5):360-76. Ann Clin Lab Sci. 1989. PMID: 2679351 Review.
-
In vitro susceptibility vs. in vivo efficacy of various antimicrobial agents against the Bacteroides fragilis group.Rev Infect Dis. 1991 Nov-Dec;13(6):1170-80. doi: 10.1093/clinids/13.6.1170. Rev Infect Dis. 1991. PMID: 1775850 Review.
Cited by
-
Adherence of Bacteroides fragilis group species.Infect Immun. 1991 Feb;59(2):742-4. doi: 10.1128/iai.59.2.742-744.1991. Infect Immun. 1991. PMID: 1670934 Free PMC article.
-
Succinic acid, a metabolic by-product of Bacteroides species, inhibits polymorphonuclear leukocyte function.Infect Immun. 1985 May;48(2):402-8. doi: 10.1128/iai.48.2.402-408.1985. Infect Immun. 1985. PMID: 3886546 Free PMC article.
-
Virulence of enterococci.Clin Microbiol Rev. 1994 Oct;7(4):462-78. doi: 10.1128/CMR.7.4.462. Clin Microbiol Rev. 1994. PMID: 7834601 Free PMC article. Review.
-
Intra-abdominal infections in children. Pathogenesis, diagnosis and management.Drugs. 1993 Jul;46(1):53-62. doi: 10.2165/00003495-199346010-00004. Drugs. 1993. PMID: 7691507 Review.
-
Encapsulated anaerobic bacteria in synergistic infections.Microbiol Rev. 1986 Dec;50(4):452-7. doi: 10.1128/mr.50.4.452-457.1986. Microbiol Rev. 1986. PMID: 3540572 Free PMC article. Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical